Minimal Residual Disease (MRD) by Flow Cytometry

MRD testing by flow cytometry detects trace amounts of leukemia or lymphoma cells that may remain after treatment. It helps assess the risk of relapse and guide further therapeutic decisions.

Also known asMrd Flowcytometry Markers Minimal Residual Disease (mrd) By Flow Cytometry (available At Fmri - Gurgaon) Minimal Residual Disease (mrd) By Flow Cytometry (available At Fmri - Gurgaon)

Available via

Home Collection, Lab Visit

Contains

2 parameters

Earliest reports in

3 Working Days

Test details

Minimal Residual Disease (MRD) by Flow Cytometry Test in Mangaluru Overview

What is the Minimal Residual Disease (MRD) by Flow Cytometry test?

The Minimal Residual Disease (MRD) by Flow Cytometry test is used to detect small numbers of remaining cancer cells in blood or bone marrow after leukemia or lymphoma treatment. The test uses flow cytometry technology to identify abnormal cells with high sensitivity.

Why is the Minimal Residual Disease (MRD) by Flow Cytometry test done?

  • To evaluate treatment response in leukemia and lymphoma patients.
  • To detect residual cancer cells after therapy.
  • To assess the risk of disease relapse.
  • To monitor remission status.
  • To support long-term cancer management.

Who should get tested for the Minimal Residual Disease (MRD) by Flow Cytometry test?

  • Patients undergoing treatment for leukemia or lymphoma.
  • Individuals in remission requiring disease monitoring.
  • Patients with suspected residual blood cancer cells.
  • Individuals advised by haematologists for MRD evaluation.

More about the Minimal Residual Disease (MRD) by Flow Cytometry test

MRD testing is an important part of modern cancer care because even a very small number of residual cancer cells can increase the risk of relapse. The test is commonly performed using blood or bone marrow samples.

Other/Similar names of the test

  • MRD Flow Cytometry Test
  • Residual Leukemia Cell Detection
  • Leukemia Remission Monitoring Test
  • Flow Cytometry MRD Analysis
  • Measurable Residual Disease
Preparations

No special preparations needed

Test included
Minimal Residual Disease (MRD) by Flow Cytometry includes 2 parameters

  • Specimen Type
  • Comments

Test code

2015

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Bone MarrowOthers
Bone Marrow HeparinGreen Vacutainer
Bone Marrow SmearSlider Mail Box

Specimen stability information

Bone Marrow, Bone Marrow Heparin, Bone Marrow Smear

Collection instructions

Clinical history (Sample should reach within 24hrs of collection). Sample should reach laboratory preferably within 24 hrs of collection. Filled history sheet, initial Immunophenotyping report/data

Specimen rejection criteria

Test run frequency

'

Turn around time

3 Working Days

Performing locations

Department

  • Flow Cytometry

CPT and Loinc codes

Minimal Residual Disease (MRD) by Flow Cytometry

15000